Table 2. Survival characteristics of the 49 patient validation cohort.
Validation cohort (n = 49) | |||
---|---|---|---|
Risk Category | # Patients | % Patients | % Disease free survival (5 yr) |
Low | 16 | 33 | 94 |
High | 33 | 67 | 48 |
Validation cohort (n = 49) | |||
---|---|---|---|
Risk Category | # Patients | % Patients | % Disease free survival (5 yr) |
Low | 16 | 33 | 94 |
High | 33 | 67 | 48 |